The effect on HbA1c levels of age and gender in adults without diabetes mellitus

Keywords: Diabetes mellitus; HbA1c; gender; age; correlation

Abstract


Background: Hemoglobin A1c (HbA1c) levels play an important role in the diagnosis, screening, and monitoring of treatment in diabetes. The aim of our study is to determine whether there is a relationship between HbA1c levels and age and gender in Turkish adults who have not been diagnosed with diabetes.

Materials and Methods: This retrospective study included 6776 Turkish adults with no known diabetes. Cross-sectional analyzes of A1C levels were performed between different age and gender categories. In statistical analysis, t-test, linear regression analysis, one-way ANOVA analysis, and LSD post hoc were used.

Results: HbA1c levels in the individuals examined by dividing into different age groups increased with age in all groups. In our study, HbA1c levels were significantly higher in males than females (p < 0.001) in all groups, especially between the ages of 30-49, and were positively associated with age for males and females. There was a positive correlation between HbA1c and age in both men and women aged 30-49 years (P < 0.05). In the HbA1c ≥ 6.5% group newly diagnosed with diabetes, HbA1c levels gradually decreased with age in both genders, and no significant effect of age on Hb1Ac level was detected (p > 0.05).

Conclusions: Our results showed that it is important to evaluate the effects of age and gender when using HbA1c levels in the diagnosis, screening, and treatment of diabetes, especially in the young and middle-aged population. Applying this situation to daily practice may reduce the misdiagnosis of diabetes in elderly patients, overtreatment of diabetes, and its associated risks.

References



  • 1. Nakashima K, Nishizaki O, Andoh Y. Acceleration of hemoglobin glycation with aging. Clin Chim Acta 1993;16:111-8. doi: 10.1016/0009-8981(93)90254-2.






  1. 2. Bellary S, Kyrou I, Brown JE, Bailey CJ. Type 2 diabetes mellitus in older adults: clinical considerations and management. Nat Rev Endocrinol 2021;17:534-548. doi: 10.1038/s41574-021-00512-2.




  2. 3. American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care 2021;44:S15-S33. doi: 10.2337/dc21-S002.




  3. 4. Hovestadt I, Kiess W, Lewien C, Willenberg A, Poulain T, Meigen C, et al. HbA1c percentiles and the association between BMI, age, gender, puberty, and HbA1c levels in healthy German children and adolescents. Pediatr Diabetes 2022;23:194-202. doi: 10.1111/pedi.13297.




  4. 5. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia 2008;51:8-11. doi: 10.1007/s00125-007-0873-z




  5. 6. Qi J, Su Y. Song Q, Ding Z, Cao M, Cui B, et al. Reconsidering the HbA1c Cutoff for Diabetes Diagnosis Based on a Large Chinese Cohort. Exp Clin Endocrinol Diabetes 2021;129:86-92. doi: 10.1055/a-0833-8119.




  6. 7. Florkowski C. HbA1c as a Diagnostic Test for Diabetes Mellitus—Reviewing the Evidence. Clin Biochem Rev 2013;34:75-83. PMID:24151343




  7. 8. Roth J, Müller N, Lehmann T, Heinemann L, Wolf G, Müller UA. HbA1c and Age in Non-Diabetic Subjects: An Ignored Association? Exp Clin Endocrinol Diabetes 2016;124:637-642. doi: 10.1055/s-0042-105440.




  8. 9. American Diabetes Association. Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes 2015;33:97-111. doi: 10.2337/diaclin.33.2.97.




  9. 10. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT research group. Diabetes 1986;35:530-45.




  10. 11. Greco D, Angileri G: Drug-induced severe hypoglycemia in type 2 diabetic patients aged 80 years or older. Diabetes Nutr Metab 2004;17:23-6.




  11. 12. Huang SH, Huang PJ, Li JY, Su YD, Lu CC, Shih CL. Hemoglobin A1c Levels Associated with Age and Gender in Taiwanese Adults without Prior Diagnosis with Diabetes. Int J Environ Res Public Health 2021;18:3390. doi: 10.3390/ijerph18073390.




  12. 13. Hashimoto Y, Futamura A, Ikushima M: Effect of aging on HbAlc in a working male Japanese population. Diabetes Care 1995;18:1337-40. doi: 10.2337/diacare.18.10.1337.




  13. 14. Dukes PP, Goldwasser E. Inhibition of erythropoiesis by estrogens. Endocrinology 1961;69:21-9. doi: 10.1210/endo-69-1-21




  14. 15. Masuch A, Friedrich N, Roth J, Nauck M. Müller UA. Petersmann A. Preventing misdiagnosis of diabetes in the elderly: age-dependent HbA1c reference intervals derived from two population-based study cohorts. BMC Endocr Disord 2019;19:20. doi: 10.1186/s12902-019-0338-7.




  15. 16. Ma Q, Liu H, Xiang G, Shan W, Xing W. Association between glycated hemoglobin A1c levels with age and gender in Chinese adults with no prior diagnosis of diabetes mellitus. Biomed Rep 2016;4:737-740. doi: 10.3892/br.2016.643.




  16. 17. Pani LN, Korenda L, Meigs JB, Driver C, Chamany S, Fox CS. et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2008;31:1991-6. doi:10.2337/dc08-0577.




  17. 18. Wu L, Lin H, Gao J, Li X, Xia M, Wang D, et al. Effect of age on the diagnostic efficiency of HbA1c for diabetes in a Chinese middle-aged and elderly population: The Shanghai Changfeng Study. PLoS One 2017;12(9):e0184607. doi:10.1371/journal.pone.0184607




  18. 19. Yang YC, Lu FH, Wu JS, Chang CJ. Age and sex effects on HbA1c. A study in a healthy Chinese population. Diabetes Care 1997;20:988-91. doi: 10.2337/diacare.20.6.988.




  19. 20. Yang L, Shen X, Yan S, Xu F, Wu P. The effectiveness of age on HbA1c as a criterion for the diagnosis of diabetes in Chinese different age subjects. Clin Endocrinol (Oxf) 2015;82:205-12. doi: 10.1111/cen.12494.




  20. 21. Cohen RM, Franco RS, Khera PK, Smith EP, Lindsell CJ, Ciraolo PJ, et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008;112:4284–91.




  21. 22. Virtue MA, Furne JK, Nuttall FQ, Levitt MD. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 2004;27:931-5. doi: 10.2337/diacare.27.4.931.




  22. 23. Peschle C, Magli MC, Cillo C, Lettieri F, Cacciapuoti A, Pizzella F, et al. Erythroid colony formation and erythropoietin activity in mice treated with estradiol benzoate. Life Sci 1977;21:1303-10. doi: 10.1016/0024-3205(77)90011-x.




  23. 24. Walton C, Godsland IF, Proudler AJ, Wynn V, Stevenson JC. The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese. healthy women. Eur J Clin Invest 1993;23:466-73. doi: 10.1111/j.1365-2362.1993.tb00792.x.




  24. 25. Simon D, Senan C, Garnier P, Saint-Paul M, Papoz L. Epidemiological features of glycated hemoglobin A1c-distribution in a healthy population. The Telecom Study, Diabetologia 1989;32:864-9. doi: 10.1007/BF00297451.




  25. 26. Aydın D, Erbas B, Karakus N, Aydın O, K-Ozkan S. Sun exposure and age at natural menopause: a cross-sectional study in Turkish women. Maturitas 2005;52:235-48. doi: 10.1016/j.maturitas.2005.02.023. 






Published
2023/07/20
Section
Original paper